Live September 30 webinar introduces frameworks for evaluating, initiating and managing BHRT in practice; free to attend, with optional CME credit available.

This program lays out that foundation: the physiology, the regulatory landscape, and the factors worth considering before evaluating a compounded option.”

— Christine Stephanos

BERKELEY, CA, UNITED STATES, August 13, 2026 /EINPresswire.com/ — Live September 30 webinar introduces frameworks for evaluating, initiating and managing bioidentical hormone therapy in practice; free to attend, with optional CME credit available to physicians, nurse practitioners, physician associates, and other licensed healthcare providers.

Hormone health is one of the fastest-growing conversations in patient care, and BHRT is a nuanced, evolving area that most medical and pharmacy curricula only touch on briefly. This session gives prescribers a chance to build on what they already know, with a practical, evidence-based framework taught directly by Valor’s own licensed compounding pharmacist. Registration is free; providers who would like to receive CME credits for the training can add it for a one-time $99 fee.

Valor Compounding Pharmacy, a multi-state licensed 503A compounding pharmacy based in Berkeley, California, today announced it will host its first continuing medical education (CME)-certified webinar, “Bioidentical Hormone Replacement Therapy (BHRT): An Introductory Guide for Prescribers,” on Wednesday, September 30, 2026, from 10:00 a.m. to 11:15 a.m. PST (1:00 p.m. to 2:15 p.m. EST). Registration is free and open to physicians, nurse practitioners, physician associates and other licensed healthcare providers. Providers who wish to receive CME credit for attending can add it to their registration for a one-time fee of $99.

Valor is one of a small number of compounding pharmacies offering CME-certified training for prescribers. The introductory-level program is designed for providers who are new to BHRT, or who want to revisit the fundamentals, and covers the regulatory distinctions between compounded and FDA-approved options along with the physiology and lab-based decision-making the topic involves.

Led by Christine Stephanos, RPh, BCSCP, Valor’s VP & Chief Pharmacy Officer, the session will cover the endogenous hormone pathways relevant to menopausal and perimenopausal care; how compounded BHRT differs from FDA-approved hormone therapy with respect to evidence and regulatory status; the current regulatory landscape governing hormone therapy and compounded preparations; how to interpret relevant laboratory testing to inform individualized treatment decisions; and the clinical factors providers weigh when considering whether a compounded formulation may be appropriate for a given patient. The program concludes with 15 minutes of live Q&A.

“Providers regularly ask our pharmacists questions related to hormone health, and many are looking for a clear, well-organized way to work through the evidence before making a clinical decision,” said Christine Stephanos, RPh, BCSCP, VP & Chief Pharmacy Officer at Valor Compounding Pharmacy. “This program lays out that foundation: the physiology, the regulatory landscape, and the factors worth considering before evaluating a compounded option.”

The introductory program is designed for physicians, physician associates, nurse practitioners and other healthcare professionals interested in bioidentical hormone therapy, including those practicing in integrative medicine, functional medicine, women’s health and endocrinology-focused care.

Registration is free and open now at valorcompounding.com/cme-webinar. Providers who want to receive CME credit can add it during registration for a one-time $99 fee. Space is limited.

Accreditation & Disclosures

In support of improving patient care, this activity has been planned and implemented by Valor Compounding Pharmacy and CME Outfitters, LLC. CME Outfitters, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. CME Outfitters, LLC designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Disclosures: Christine Stephanos, RPh, BCSCP, has nothing to disclose. Planning Committee Disclosures: Daniela Jones, Marie Judkins, Shari Tordoff and Imman Rathore have nothing to disclose. All relevant financial relationships have been mitigated.

Unlabeled Use Disclosure: Faculty of this CME/CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses of products or devices. CME Outfitters, LLC, the faculty, and Valor Compounding Pharmacy do not endorse the use of any product outside of its FDA-labeled indications. Medical professionals should not utilize the procedures, products or diagnostic techniques discussed during this activity without evaluating their patient for contraindications or dangers of use.

This educational activity is intended for licensed healthcare professionals. Content is for educational purposes only and does not constitute medical, legal or regulatory advice. Clinical decisions should be made based on independent professional judgment and applicable laws and guidelines. Compounded medications are not FDA-approved, meaning they have not been evaluated by the U.S. Food and Drug Administration for safety or effectiveness; Valor makes no claims regarding the safety or effectiveness of any compounded preparation.

About Valor Compounding Pharmacy

Valor Compounding Pharmacy, Inc. is a multi-state licensed 503A compounding pharmacy headquartered in Berkeley, California, operating both sterile and non-sterile laboratories. The pharmacy prepares customized medications based on valid prescriptions from licensed providers and offers provider education, including CME-certified training, to support licensed clinicians in their own independent decision-making. Sterile medications are available in California; non-sterile medications are available in all states Valor serves. Learn more at valorcompounding.com.

Media Contact
Valor Compounding Pharmacy
+1 510-447-7332
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Media gallery

About The Author